17th Invitation to Manufacturers of Reproductive Health Medicines to Submit an Expression of Interest (EOI) for Product Evaluation by the WHO Expert Review Panel (ERP) for Pharmaceutical Products for

UNFPA
17th Invitation to Manufacturers of Reproductive Health Medicines to Submit an Expression of Interest (EOI) for Product Evaluation by the WHO Expert Review Panel (ERP) for Pharmaceutical Products for Request for EOI

Reference: UNFPA/DNK/EOI/20/011
Beneficiary countries or territories: Multiple destinations (see the Countries or territories tab)
Published on: 27-May-2020
Deadline on: 26-Jun-2020 17:00 (GMT 2.00)

Description

17th Invitation to Manufacturers of Reproductive Health Medicines to Submit an Expression of Interest (EOI) for Product Evaluation by the WHO Expert Review Panel (ERP) for Pharmaceutical Products for the Prevention and

  • Treatment of Eclampsia,
  • Prevention and Treatment of Post-Partum Heamorrhage (Uterotonics, antifibrinolytics) and ​​​​​​​
  • Augmentation of Labour